| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10549-017-4151-6 |
| P8608 | Fatcat ID | release_6k5uekkribd5pfqo74xc3nlvzm |
| P932 | PMC publication ID | 5387012 |
| P698 | PubMed publication ID | 28205042 |
| P50 | author | Elisabeth Christine Inwald | Q91810928 |
| P2093 | author name string | O Ortmann | |
| M Evert | |||
| F Hofstädter | |||
| F Zeman | |||
| M Klinkhammer-Schalke | |||
| M Koller | |||
| G Brockhoff | |||
| P2860 | cites work | Declined guideline adherence in older breast cancer patients: a population-based study in the Netherlands. | Q51478985 |
| Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. | Q51609853 | ||
| 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. | Q53243856 | ||
| Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study. | Q54593797 | ||
| Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer | Q63365966 | ||
| Tumor characteristics and clinical outcome of elderly women with breast cancer | Q73631132 | ||
| Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort | Q79748458 | ||
| Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study | Q81514278 | ||
| Breast cancer in the elderly | Q82909300 | ||
| Prognostic factors in elderly patients with breast cancer | Q26852883 | ||
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Adjuvant treatment for older women with invasive breast cancer | Q28066744 | ||
| Specific Aspects of Breast Cancer Therapy of Elderly Women | Q28079170 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials | Q29547513 | ||
| Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015). | Q30316383 | ||
| Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study. | Q34049037 | ||
| Age-specific changes in intrinsic breast cancer subtypes: a focus on older women | Q34359310 | ||
| Adjuvant chemotherapy in older women with early-stage breast cancer | Q34858284 | ||
| RETRACTED ARTICLE: Undertreatment of breast cancer in the elderly | Q35051048 | ||
| Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 | Q35130819 | ||
| Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction | Q35558070 | ||
| Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer | Q36059237 | ||
| 4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival | Q36109274 | ||
| Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry | Q36240949 | ||
| Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years | Q36610253 | ||
| Critical review of the management of early-stage breast cancer in elderly women | Q36742697 | ||
| Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry | Q36892788 | ||
| Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility. | Q37383276 | ||
| Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012. | Q37657782 | ||
| Guideline concordant therapy prolongs survival in HER2-positive breast cancer patients: results from a large population-based cohort of a cancer registry | Q37687943 | ||
| Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). | Q37999119 | ||
| Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: a systematic review of randomized controlled trials. | Q38006133 | ||
| Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study | Q38384241 | ||
| Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. | Q39878405 | ||
| Tumor characteristics and therapy of elderly patients with breast cancer | Q40063178 | ||
| Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients | Q41134890 | ||
| Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial | Q46736552 | ||
| Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated? | Q47758761 | ||
| 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial | Q47973074 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 119-130 | |
| P577 | publication date | 2017-02-15 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology | |
| P478 | volume | 163 |
| Q47615349 | Long intergenic non-protein coding RNA 1006 used as a potential novel biomarker of gastric cancer |
| Q47680847 | Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC-Twenty-Three Randomized Trial |
| Q89068478 | Receipt of Guideline-Concordant Care Among Older Women With Stage I-III Breast Cancer: A Population-Based Study |
Search more.